These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 7793450

  • 1. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder.
    Benjamin J, Levine J, Fux M, Aviv A, Levy D, Belmaker RH.
    Am J Psychiatry; 1995 Jul; 152(7):1084-6. PubMed ID: 7793450
    [Abstract] [Full Text] [Related]

  • 2. Controlled trials of inositol in psychiatry.
    Levine J.
    Eur Neuropsychopharmacol; 1997 May; 7(2):147-55. PubMed ID: 9169302
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder.
    Palatnik A, Frolov K, Fux M, Benjamin J.
    J Clin Psychopharmacol; 2001 Jun; 21(3):335-9. PubMed ID: 11386498
    [Abstract] [Full Text] [Related]

  • 4. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.
    Depress Anxiety; 2007 Jun; 24(1):1-14. PubMed ID: 16894619
    [Abstract] [Full Text] [Related]

  • 5. Inositol treatment of obsessive-compulsive disorder.
    Fux M, Levine J, Aviv A, Belmaker RH.
    Am J Psychiatry; 1996 Sep; 153(9):1219-21. PubMed ID: 8780431
    [Abstract] [Full Text] [Related]

  • 6. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.
    Mavissakalian MR, Perel JM.
    Am J Psychiatry; 1995 May; 152(5):673-82. PubMed ID: 7726306
    [Abstract] [Full Text] [Related]

  • 7. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.
    Lesser IM, Lydiard RB, Antal E, Rubin RT, Ballenger JC, DuPont R.
    Am J Psychiatry; 1992 Nov; 149(11):1556-62. PubMed ID: 1415824
    [Abstract] [Full Text] [Related]

  • 8. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
    Carter CS, Fawcett J, Hertzman M, Papp LA, Jones W, Patterson WM, Swinson RP, Weise CC, Maddock RJ, Denahan AQ.
    J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
    [Abstract] [Full Text] [Related]

  • 9. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
    Bakish D, Hooper CL, Filteau MJ, Charbonneau Y, Fraser G, West DL, Thibaudeau C, Raine D.
    Psychopharmacol Bull; 1996 May; 32(1):135-41. PubMed ID: 8927663
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Crossover trial of pagoclone and placebo in patients with DSM-IV panic disorder.
    Sandford JJ, Forshall S, Bell C, Argyropoulos S, Rich A, D'Orlando KJ, Gammans RE, Nutt DJ.
    J Psychopharmacol; 2001 Sep; 15(3):205-8. PubMed ID: 11565630
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diazepam versus alprazolam for the treatment of panic disorder.
    Noyes R, Burrows GD, Reich JH, Judd FK, Garvey MJ, Norman TR, Cook BL, Marriott P.
    J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder.
    Kramer MS, Cutler NR, Ballenger JC, Patterson WM, Mendels J, Chenault A, Shrivastava R, Matzura-Wolfe D, Lines C, Reines S.
    Biol Psychiatry; 1995 Apr 01; 37(7):462-6. PubMed ID: 7786960
    [Abstract] [Full Text] [Related]

  • 17. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.
    Lydiard RB, Lesser IM, Ballenger JC, Rubin RT, Laraia M, DuPont R.
    J Clin Psychopharmacol; 1992 Apr 01; 12(2):96-103. PubMed ID: 1573046
    [Abstract] [Full Text] [Related]

  • 18. Effect of fluvoxamine on panic disorder.
    Hoehn-Saric R, McLeod DR, Hipsley PA.
    J Clin Psychopharmacol; 1993 Oct 01; 13(5):321-6. PubMed ID: 8227490
    [Abstract] [Full Text] [Related]

  • 19. Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone.
    de Beurs E, van Balkom AJ, Lange A, Koele P, van Dyck R.
    Am J Psychiatry; 1995 May 01; 152(5):683-91. PubMed ID: 7726307
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.